Selected research
Industry Research
Molecular Imaging Agents Industry Research Report 2026
Market perspective
The global Molecular Imaging Agents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Molecular Imaging Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Molecular Imaging Agents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Molecular Imaging Agents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Molecular Imaging Agents include Eisai, Guerbet, General Electric and Bracco Diagnostic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Molecular Imaging Agents market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Molecular Imaging Agents Market by Company
Eisai
Guerbet
General Electric
Bracco Diagnostic
Molecular Imaging Agents Segment by Type
Engineered Protein Fragments
Nanoparticles
Aptamers
Peptides
Small Molecules
Others
Molecular Imaging Agents Segment by Application
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Others
Molecular Imaging Agents Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Imaging Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Imaging Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Imaging Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Molecular Imaging Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Molecular Imaging Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Molecular Imaging Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Engineered Protein Fragments
- Nanoparticles
- Aptamers
- Peptides
- Small Molecules
- Others
Applications
- Oncology
- Cardiology
- Gastrointestinal Disorders
- Neurology Disorders
- Others
Companies covered
- Eisai
- Guerbet
- General Electric
- Bracco Diagnostic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Molecular Imaging Agents Market Size (2021-2032)
- 2.2.2 Global Molecular Imaging Agents Sales (2021-2032)
- 2.2.3 Global Molecular Imaging Agents Market Average Price (2021-2032)
- 2.3 Molecular Imaging Agents by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Engineered Protein Fragments
- 2.3.3 Nanoparticles
- 2.3.4 Aptamers
- 2.3.5 Peptides
- 2.3.6 Small Molecules
- 2.3.7 Others
- 2.4 Molecular Imaging Agents by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oncology
- 2.4.3 Cardiology
- 2.4.4 Gastrointestinal Disorders
- 2.4.5 Neurology Disorders
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Molecular Imaging Agents Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Molecular Imaging Agents Sales (K Tons) of Manufacturers (2021-2026)
- 3.3 Global Molecular Imaging Agents Revenue of Manufacturers (2021-2026)
- 3.4 Global Molecular Imaging Agents Average Price by Manufacturers (2021-2026)
- 3.5 Global Molecular Imaging Agents Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Molecular Imaging Agents, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Molecular Imaging Agents, Product Type & Application
- 3.8 Global Manufacturers of Molecular Imaging Agents, Established Date
- 3.9 Global Molecular Imaging Agents Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Eisai
- 4.1.1 Eisai Company Information
- 4.1.2 Eisai Business Overview
- 4.1.3 Eisai Molecular Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Eisai Molecular Imaging Agents Product Portfolio
- 4.1.5 Eisai Recent Developments
- 4.2 Guerbet
- 4.2.1 Guerbet Company Information
- 4.2.2 Guerbet Business Overview
- 4.2.3 Guerbet Molecular Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Guerbet Molecular Imaging Agents Product Portfolio
- 4.2.5 Guerbet Recent Developments
- 4.3 General Electric
- 4.3.1 General Electric Company Information
- 4.3.2 General Electric Business Overview
- 4.3.3 General Electric Molecular Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 General Electric Molecular Imaging Agents Product Portfolio
- 4.3.5 General Electric Recent Developments
- 4.4 Bracco Diagnostic
- 4.4.1 Bracco Diagnostic Company Information
- 4.4.2 Bracco Diagnostic Business Overview
- 4.4.3 Bracco Diagnostic Molecular Imaging Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bracco Diagnostic Molecular Imaging Agents Product Portfolio
- 4.4.5 Bracco Diagnostic Recent Developments
5 Global Molecular Imaging Agents Market Scenario by Region
- 5.1 Global Molecular Imaging Agents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Molecular Imaging Agents Sales by Region: 2021-2032
- 5.2.1 Global Molecular Imaging Agents Sales by Region: 2021-2026
- 5.2.2 Global Molecular Imaging Agents Sales by Region: 2027-2032
- 5.3 Global Molecular Imaging Agents Revenue by Region: 2021-2032
- 5.3.1 Global Molecular Imaging Agents Revenue by Region: 2021-2026
- 5.3.2 Global Molecular Imaging Agents Revenue by Region: 2027-2032
- 5.4 North America Molecular Imaging Agents Market Facts & Figures by Country
- 5.4.1 North America Molecular Imaging Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Molecular Imaging Agents Sales by Country (2021-2032)
- 5.4.3 North America Molecular Imaging Agents Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Molecular Imaging Agents Market Facts & Figures by Country
- 5.5.1 Europe Molecular Imaging Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Molecular Imaging Agents Sales by Country (2021-2032)
- 5.5.3 Europe Molecular Imaging Agents Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Molecular Imaging Agents Market Facts & Figures by Country
- 5.6.1 Asia Pacific Molecular Imaging Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Molecular Imaging Agents Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Molecular Imaging Agents Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Molecular Imaging Agents Market Facts & Figures by Country
- 5.7.1 South America Molecular Imaging Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Molecular Imaging Agents Sales by Country (2021-2032)
- 5.7.3 South America Molecular Imaging Agents Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Molecular Imaging Agents Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Molecular Imaging Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Molecular Imaging Agents Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Molecular Imaging Agents Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Molecular Imaging Agents Sales by Type (2021-2032)
- 6.1.1 Global Molecular Imaging Agents Sales by Type (2021-2032) & (K Tons)
- 6.1.2 Global Molecular Imaging Agents Sales Market Share by Type (2021-2032)
- 6.2 Global Molecular Imaging Agents Revenue by Type (2021-2032)
- 6.2.1 Global Molecular Imaging Agents Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Molecular Imaging Agents Revenue Market Share by Type (2021-2032)
- 6.3 Global Molecular Imaging Agents Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Molecular Imaging Agents Sales by Application (2021-2032)
- 7.1.1 Global Molecular Imaging Agents Sales by Application (2021-2032) & (K Tons)
- 7.1.2 Global Molecular Imaging Agents Sales Market Share by Application (2021-2032)
- 7.2 Global Molecular Imaging Agents Revenue by Application (2021-2032)
- 7.2.1 Global Molecular Imaging Agents Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Molecular Imaging Agents Revenue Market Share by Application (2021-2032)
- 7.3 Global Molecular Imaging Agents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Molecular Imaging Agents Value Chain Analysis
- 8.1.1 Molecular Imaging Agents Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Molecular Imaging Agents Production Mode & Process
- 8.2 Molecular Imaging Agents Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Molecular Imaging Agents Distributors
- 8.2.3 Molecular Imaging Agents Customers
9 Global Molecular Imaging Agents Analyzing Market Dynamics
- 9.1 Molecular Imaging Agents Industry Trends
- 9.2 Molecular Imaging Agents Industry Drivers
- 9.3 Molecular Imaging Agents Industry Opportunities and Challenges
- 9.4 Molecular Imaging Agents Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst